{"name":"Megalabs","slug":"megalabs","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Granulokine","genericName":"Granulokine","slug":"granulokine","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Granulokine","genericName":"Granulokine","slug":"granulokine","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNRjRoVkJETnIxbnNwOFRYWHRJSXJ5c3A1Q2l3MW1sOU1UOVBwMkIzQ19vNXc1UVpoTGpPNVU2MHg3cFNJMXpLenVyTW1GU3ZOT0dtYU9CelI4TFFfWFM0VkpIc3I0WWdoQmZ3NGRmN0JwTXJKbjlMWGRWbDVlb0FnWnJuOWZfcGtMUWtxVnBJMjFWLUZwZmJSQ1VhSGN1dnllNlpwb2FtUzB2TzJjTWlsa01zdm5aYXlQY0FVeW4zcmNHYjBWM2c?oc=5","date":"2025-10-16","type":"deal","source":"Pearce IP","summary":"Formycon/Klinge Partners with Actor in AU and Megalabs in LATAM for Biosimilar Aflibercept - Pearce IP","headline":"Formycon/Klinge Partners with Actor in AU and Megalabs in LATAM for Biosimilar Aflibercept","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5KM0Z2bkx3ZV9QeGd6NG1XY0tiWHdKMTc1cmMyU2FUendjVkpQR1BvMjN3TnZPbG9oaXpCWHQ1YlA1NVRvNFdvbC1kNHNRMTVl?oc=5","date":"2024-05-31","type":"deal","source":"PR.com","summary":"Megalabs Acquires Majority Interest and Control of DS Laboratories - PR.com","headline":"Megalabs Acquires Majority Interest and Control of DS Laboratories","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOWEN3ZXNjdlVXU2hITV9RT1dvaG9FczA0WlZNTjV6cEFSQ3BIR0sxY3IxbGhOVEZ4eVVCVk5ob0xKaUlWS3FnX3d0LU02Sm1fZFVveVlkT2h5dlp5cEVLTmNnNm5wOGpoejFmRWs1NXZIS1ozNXVrRi1jbjl2ZVZOZVhnMHJGQkRldjk5aw?oc=5","date":"2024-05-29","type":"pipeline","source":"BeautyMatter","summary":"Megalabs Takes Majority Stake in Haircare Brand DS Labs - BeautyMatter","headline":"Megalabs Takes Majority Stake in Haircare Brand DS Labs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQMUxWUXNsZnV4aFF3UHQ5WkZuSEtKRGFwZEtDZjBBZnhtWGhfcDJRVlliWk1FcG1BdVFEZExsdFpMd0MtMEVzVzFRRjRXeVV1ZER4QmlxSVM5MEtxUV9XVkRjQzJFMU9nWG41X1pEclpDLUFncml2M0xNWVBnRUYxRUlRNHVxSUs0YlB1a2VmdDdvRHlkMlFCRjR3aXl4S3J3RWFWRXpYTm1aZHJ6U0RLLTREMUZiNjc0MGc?oc=5","date":"2023-10-30","type":"deal","source":"CoStar","summary":"News | Biopharma Group Completes Site Buy for Mega Labs, Offices and Manufacturing Hub - CoStar","headline":"News | Biopharma Group Completes Site Buy for Mega Labs, Offices and Manufacturing Hub","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQSWpYTFpBMGt6R2FBdUFjckZpZGlPQW9LZzI1TjVqT1pLUC14MTNqX0VXbWpQYm84bTg5ck1zZzZKNGpwOHBNeHJLcWtCa2FJc0JwRm5ycHhqdjVyNHM4UFpvUWtLQUtYUnNrbUJTTTNmcW9CTHNwdE5xeWdjRUtaMkN3WGdqRVFRME9CSkZieTN6b0YtNlllZG9qc1RkZXVpSlNxR3p0WWt1UE9GOThCQ2k3VHV1bEZFYzRTUi1MZw?oc=5","date":"2022-08-24","type":"pipeline","source":"BioSpace","summary":"Megalabs USA Announces Launch of Two New Products in North American Market: Abintra and Glutapak R - BioSpace","headline":"Megalabs USA Announces Launch of Two New Products in North American Market: Abintra and Glutapak R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQem9WRVBmQ2V4OXI1Q1VnZklyRzE0Ul9JX0lWSU81OGk1bjlNd3MzS09SajI1ZGx4clR0YkdrME44ZVRVSkRvQjF6YmZySDRINXBxNzhSNklTcjZEVkZaT3YwNWpjdlpiWGdRc3NEUGtDNk0xQzEtS0pvaTVGb3BzN3VkamNFeXBGOVV0Qw?oc=5","date":"2021-01-21","type":"pipeline","source":"worldfinance.com","summary":"When pharma leadership becomes your own choice - worldfinance.com","headline":"When pharma leadership becomes your own choice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQMUpDRmJ6UGx6em9oTGxvNXN4WUtPZFNmU1RpTDRvdHlNSjdibTdFcHJoR2ExakRPbjVwOU4wTGxoWmFEWktPM0g5MXJDbnhNd0V4eVBZZmk4c1QtTmdlb0R1SV9mRmJ1bUlTSUxfNDFGNVpvTFJHall1Y195V1JSMThLWkU0OF9iUW9mcG9vMF9hNXVhUzFkeQ?oc=5","date":"2020-06-27","type":"pipeline","source":"cfi.co","summary":"Megalabs: Best Healthcare Rebrand Latin America 2019 - cfi.co","headline":"Megalabs: Best Healthcare Rebrand Latin America 2019","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}